Your browser doesn't support javascript.
loading
Genetic study of Alport syndrome in Tunisia.
Younsi, Mariem El; Achour, Ahlem; Kraoua, Lilia; Nesrine, Mezzi; Sayari, Taha; Abderrahim, Ezzeddine; Laabidi, Janet; Zouaghi, Mohamed Karim; Kharrat, Maher; Gargah, Tahar; Trabelsi, Mediha; M'rad, Ridha.
Affiliation
  • Younsi ME; Laboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
  • Achour A; Laboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
  • Kraoua L; Service des Maladies Congénitales Et Héréditaires, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
  • Nesrine M; Laboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
  • Sayari T; Service des Maladies Congénitales Et Héréditaires, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
  • Abderrahim E; Laboratory of Biomedical Genomics and Oncogenetics, Pasteur Institute of Tunis, 1002, Tunis, Tunisia.
  • Laabidi J; Service de Néphrologie Pédiatrique, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
  • Zouaghi MK; Service de Médecine Interne Et de Néphrologie Adulte, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
  • Kharrat M; Service Néphrologie, L'Hôpital Militaire Principal d'Instruction de Tunis, MontFleury, 1008, Tunis, Tunisia.
  • Gargah T; Service de Néphrologie, Dialyse Et Transplantation Rénale, Hôpital La Rabta 1007, Tunis, Tunisia.
  • Trabelsi M; Laboratoire de Génétique Humaine, Faculté de Médecine de Tunis, Université de Tunis El Manar, LR99ES101007, Tunis, Tunisia.
  • M'rad R; Service de Néphrologie Pédiatrique, Hôpital Charles Nicolle, 1006, Tunis, Tunisia.
Pediatr Nephrol ; 2024 Aug 14.
Article in En | MEDLINE | ID: mdl-39138691
ABSTRACT

BACKGROUND:

Alport syndrome is a genetic disorder affecting the kidneys, ears, and eyes, causing chronic kidney disease, sensorineural hearing loss, and ocular abnormalities. It results from pathogenic variants in the COL4A3, COL4A4, or COL4A5 genes, with different inheritance patterns X-linked from COL4A5 variants, autosomal recessive from homozygous variants in COL4A3 or COL4A4, digenic from variants in both COL4A3 and COL4A4, and autosomal dominant from heterozygous variants in COL4A3 or COL4A4.

METHODS:

We analyzed 45 patients with Alport syndrome from 11 Tunisian families to determine their clinical and genetic characteristics. Clinical data were collected retrospectively, and whole-exome sequencing was conducted on one patient from each family. Sanger sequencing validated pathogenic variants, and cascade screening extended the analysis to 53 individuals.

RESULTS:

We identified nine likely pathogenic variants among 11 index cases six novel and three known variations. Of these, five were in COL4A3, and four were in COL4A5, with variants including frameshift, nonsense, missense, and alternative splicing. Most variations affected the Gly-XY codon. Among the 45 clinically identified siblings, 30 tested positive for Alport syndrome. The cascade screening identified 3 additional affected individuals, 10 unaffected siblings, and 10 unaffected parents. The mode of inheritance was autosomal recessive in six families and X-linked in four families.

CONCLUSIONS:

This study is the first to screen the mutational spectrum of Alport syndrome in Tunisia. It reveals novel pathogenic variants and suggests that autosomal recessive inheritance may be more common in the Tunisian population than X-linked inheritance, contrary to existing literature.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Nephrol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Nephrol Year: 2024 Document type: Article